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Abstract
Inner ear mechanosensory hair cells transduce sound and balance information. Auditory hair cells emerge from a Sox2-
positive sensory patch in the inner ear epithelium, which is progressively restricted during development. This restriction
depends on the action of signaling molecules. Fibroblast growth factor (FGF) signalling is important during sensory
specification: attenuation of Fgfr1 disrupts cochlear hair cell formation; however, the underlying mechanisms remain
unknown. Here we report that in the absence of FGFR1 signaling, the expression of Sox2 within the sensory patch is not
maintained. Despite the down-regulation of the prosensory domain markers, p27Kip1, Hey2, and Hes5, progenitors can still
exit the cell cycle to form the zone of non-proliferating cells (ZNPC), however the number of cells that form sensory cells is
reduced. Analysis of a mutant Fgfr1 allele, unable to bind to the adaptor protein, Frs2/3, indicates that Sox2 maintenance
can be regulated by MAP kinase. We suggest that FGF signaling, through the activation of MAP kinase, is necessary for the
maintenance of sensory progenitors and commits precursors to sensory cell differentiation in the mammalian cochlea.
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Introduction
The mammalian cochlea transduces sound using a dedicated
sensory organ, the organ of Corti, which comprises of a highly
ordered array of mechanosensory hair cells (HCs) and their
associated support cells (SCs). The arrangement of cochlear HCs,
3 rows of outer hair cells (OHCs) and one row of inner hair cells
(IHCs), together with SCs results from a balance between
specification, progenitor expansion and differentiation [1].
The first step in HC specification is the induction of a Sox2-
positive territory known as the sensory patch. Sox2 is critical for
neurosensory precursor formation in the inner ear [2–4] and is
induced by Notch signalling through its ligand Jagged (Jag)1 [5–9].
BMP signalling [10] then specifies the prosensory domain, the
immediate precursors of the HCs and SCs, from within this Sox2-
positive sensory patch. At specification, the prosensory domain
exits the cell cycle, expressing the cell cycle inhibitor p27Kip1 as
well as other prosensory domain markers. Importantly, the
prosensory domain first becomes post-mitotic at the apical
end of the cochlea from E12.5, spreading basally until E14.5
[11,12].
HCs and SCs are picked out from within the prosensory domain
through Notch signalling from putative SCs, acting on Delta1 or
Jag2 in potential HCs [5,13–15]. This lateral inhibition ensures
that only some of the cells of the prosensory domain retain the
transcription factor Atoh1 [16,17]. Atoh1 is both necessary and
sufficient for HC differentiation [18]. In contrast to the apical to
basal wave of cell cycle exit of the prosensory domain, the wave of
differentiation occurs basally at E14.5 extending apically at E17.5
[19].
In addition to the above, fibroblast growth factor (FGF)
signalling has also been shown to be important in the development
of the cochlear HC. Conditional deletion of Fgf receptor (Fgfr) 1,
results in the loss of HCs [20]. This phenotype is observed to a
lesser extent, when the proposed ligand for FGFR1, Fgf20, is
deleted [21]. Ex vivo explant studies suggest that FGF signalling
enhances Notch-Jag signalling after sensory patch induction [22].
However the in vivo significance of these observations and how they
lead to the Fgfr1 deletion phenotype are not clear.
Fgf ligand binding causes the dimerization and activation of the
canonical receptor tyrosine kinase [23]. Activation, generally by
phosphorylation of particular tyrosine residues in the intracellular
domain of the Fgf receptor, results in recruitment of adaptor
proteins that are essential for the intracellular response to the
extracellular signal. Each group of phosphorylated residues mediate
distinct functions, for example phosphorylation of tyrosine 766 in
FGFR1 serves as a potential binding site for phospholipase C-c
(PLCc) [24]. Other adaptor proteins include Fgf Receptor Substrate
(Frs) 2 or 3 (collectively termed Frs2/3) [25,26]. Frs2/3 recruitment
and activation leads to the stimulation of multiple FGFR-dependent
signaling pathways such as Ras/MAP kinase pathway, and the
phosphatidylinositol-3-kinase (PI3K) pathway [27]. Studies into a
mouse allele in which the Frs2/3 interaction motif has been deleted,
reveal that Frs2/3 recruitment mediates aspects of FGFR1
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signalling [28]. However, the necessity of these pathways in inner
ear development had not been investigated.
In this study, we found that FGFR1 signalling through Frs2/3 is
necessary for prosensory formation. Even in the absence of FGFR1-
Frs2/3 signalling, the prosensory domain becomes post-mitotic,
however the expression of prosensory markers is impaired. This
results in fewer sensory precursors, giving rise to a reduction in HC
numbers. We also found that the expression of Sox2 is transient,
suggesting that the strength and duration of Sox2 expression, under
the direct or indirect control of FGF-mediated MAP kinase
activation, commits progenitors to sensory cell differentiation.
Results
FGFR1 signalling through Frs2/3 recruitment is required
for normal cochlear hair cell development
To determine gross morphology, the inner ear from Six1enh21-
Cre::Fgfr1flox/flox and Fgfr1DFrs/DFrs at E14.5 were examined first by
paint-filling [29]. The cochlear duct of the conditional mutant
(Six1enh21-Cre::Fgfr1flox/flox) was shorter than control (Figure 1A and
B). Fgfr1DFrs/DFrs also exhibited a truncated cochlear duct although
the phenotype was milder than that of the conditional mutant
(Figure 1C). No significant difference in the formation of vestibular
components was observed.
A requirement for FGFR1 function in cochlear HC develop-
ment had been previously shown [20], however the mechanisms
used remained unknown. We asked when FGFR1 signalling was
acting during HC development, by exploiting the difference in the
timing activation of of two different Cre driver lines. To first verify
Cre activity, we crossed these lines with a Rosa26-flox-STOP-flox-
EYFP reporter, in which the expression of EYFP is initiated after the
Cre-mediated excision of the STOP, transcription terminator
sequence. Six1enh21-Cre activity can be detected as early as E9.5
specifically in whole otic epithelium (Figure 2A–C and G). In
contrast, Emx2-Cre activity cannot be detected at E9.5, but is active
at E12.5, with EYFP labelled in the almost all putative sensory
organs except three semicircular ampullae (Figure 2D–G and data
not shown). Quantitative PCR for the deleted portion of Fgfr1
confirmed the temporal activity of the two Cre lines (Figure 2H).
Fgfr1 levels in the cochlear rudiment were reduced to approximately
20% of normal in Six1enh21-Cre::Fgfr1flox/flox from E10.5. In contrast,
Fgfr1 levels in Emx2-Cre::Fgfr1flox/flox cochleae were close to wild-type
levels at E10.5, falling to 60% at E12.5 and 20% by E14.5. We thus
used these lines to examine the cochlear phenotypes when Fgfr1
deletion occurred at around E9.5 to 10.5 (using Six1enh21-Cre) or at
around E12.5 (using Emx2-Cre).
To investigate HC phenotype, whole-mount cochlear samples
from E18.5 mice were dissected and immunostained for Myo7a.
Control, wild-type, cochleae showed the typical arrangement of
three rows of OHCs and one row of IHCs along the entire length of
the cochlea (Figure 3A, B). In Six1enh21-Cre::Fgfr1flox/flox the
arrangement of HCs was altered, with those in the apical third of
the cochlea more severly affected (Figure 3C–E). Here the rows of
HCs were discontinuous, and arranged in islands. Typically, OHCs
were missing, although isolated OHCs could be found basally. The
cochlear phenotype of Emx2-Cre::Fgfr1flox/flox inner ears was milder
(Figure 3F–H). Basally, OHC loss was less pronounced with the
outer-most row most severely affected (Figure 3F). Further apically,
the HC row became discontinuous, and islands that were present
were made up of IHCs and OHCs, with occasional additional IHCs
observed (Figure 3G). HCs were more sparsely distributed in the
apical-most part of the cochlea (Figure 3H).
We next addressed the downstream pathway employed by
FGFR1 during cochlear HC formation using two alleles of Fgfr1,
Fgfr1DFrs/DFrs and Fgfr1Y766F/Y766F. Y766F carries a point mutation
converting a tyrosine at position 766 to a phenylalanine, rendering
it resistant to phosphorylation. This has been postulated to result
in a failure of PLCc phosphorylation and thus its activation [30].
The cochlear HC phenotype of Fgfr1DFrs/DFrs inner ears closely
resembled that of Six1enh21-Cre::Fgfr1flox/flox, showing the severe
OHC loss apically and the islands of HCs (Figure 3I–K). In
contrast, surface preparations from the inner ear of Fgfr1Y766F/Y766F
showed that cochlear HCs were normal (Figure 3L). The
correspondance of the HC phenotypes was confirmed after
quantifying the number of cochlear HCs, and also compared to
the previously published Foxg1-Cre::Fgfr1flox/flox [20]. The total
number of HCs per cochlea averaged 24946160 (n= 4) in wild-
type controls. There were 201626 (n= 4) HCs in Six1enh21-
Cre::Fgfr1flox/flox inner ears, 218644 in Foxg1-Cre::Fgfr1flox/flox cochlea
(n= 4), 7286274 (n= 6) in Emx2-Cre::Fgfr1flox/flox, 420660 (n= 5) in
Fgfr1DFrs/DFrs, and 2532623 (n= 6) in Fgfr1Y766F/Y766F (mean6 SD,
Figure 1. Inner ear development is disrupted in Fgfr1 mutants.
(A) The morphology of the inner ear was revealed by the injection of
white paint. Control inner ears show a typical morphology consisting of
3 semi-circular canals and the spiral cochlear duct that is 1.5 turns long.
(B) The inner ear of Six1enh21-Cre:: Fgfr1flox/flox exhibits only 1 turn of the
cochlear duct (asterix). Vestibular components are unaffected. (C)
Fgfr1DFrs/DFrs inner ear shows milder cochlear phenotype than that of
Six1enh21-Cre::Fgfr1flox/flox with a slightly shortened cochlear duct
(asterix). cd, cochlear duct; u, utricle; s, saccule; psc, posterior
semicircular canal; asc, anterior semicircular canal; lsc, lateral semicir-
cular canal; cc, common crus; a, anterior; v, ventral.
doi:10.1371/journal.pgen.1004118.g001
Author Summary
The ability of our brain to perceive sound depends on its
conversion into electrical impulses within the cochlea of
the inner ear. The cochlea has dedicated specialized cells,
called inner ear hair cells, which register sound energy.
Environmental effects, genetic disorders or just the
passage of time can damage these cells, and the damage
impairs our ability to hear. If we could understand how
these cells develop, we might be able to exploit this
knowledge to generate new hair cells. In this study we
address an old problem: how do signals from the fibroblast
growth factor (FGF) family control hair cell number? We
used mice in which one of the receptors for FGF (Fgfr1) is
mutated and found that the expression of a stem cell
protein, Sox2 is not maintained. Sox2 generally acts to
keep precursors in the cochlea in a pre-hair cell state.
However, in mutant mice Sox2 expression is transient,
diminishing the ability of precursors to commit to a hair
cell fate. These findings suggest that it may be possible to
amplify the number of hair cell progenitors in culture by
tuning FGF activity, providing a route to replace damaged
inner ear hair cells.
Fgfr1 Signalling in Sensory Progenitor Maintenance
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Figure 2. Spatio-temporal activity of conditional Cre drivers. (A–F) EYFP expression under control of Six1enh21-Cre or Emx2-Cre at E9.5, E10.5,
and E12.5. Six1enh21-Cre-mediated EYFP expression is detectable in a majority of otic cells, marked by Pax2, by E9.5 (A). All of Sox2 expressing otic
cells colocalize with Cre-mediated EYFP by E10.5 (B). The early activity results in detectable EYFP expression in the spiral ganglion cells as well as
epithelial cells that include sensory competent cells marked by Sox2 at E12.5 (C). In contrast, very few Emx2-Cre-mediated EYFP expressing cells can
be detected at E9.5 (D). The onset of Emx2-Cre activity in the inner ear is around E10.5 in the lateral wall of otocyst (E), and becomes uniform by E12.5
throughout the cochlear duct (F). (G) Schematic illustration depicting spatio-temporal activity (green) of each Cre driver during inner ear
development. (H) RT-PCR analysis showing temporal deletion of Fgfr1 by two Cre lines. Mean 6 SD are shown. cd, cochlear duct; u, utricle; s, saccule;
psc, posterior semicircular canal; asc, anterior semicircular canal; lsc, lateral semicircular canal; l, lateral; v, ventral; p, posterior; SGNs, spiral ganglion
neurons. Scale bars: A, B, D, and E, 75 mm (in E); C and F, 150 mm (in F).
doi:10.1371/journal.pgen.1004118.g002
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respectively) (Figure 3M). The significant difference was also
determined when comparing Six1enh21-Cre::Fgfr1flox/flox and Emx2-
Cre::Fgfr1flox/flox cochleae (p,0.05). Given the differences in the
timing of the two Cre drivers (Figure 2), these results suggest that
FGFR1 signalling commences prior to E12.5.
Next we counted the number of IHCs and OHCs (Figure 3M).
By comparisons with control cochlea (18766160), OHC loss
were evident in Six1enh21-Cre::Fgfr1flox/flox (22614, decreased by
99%), Emx2-Cre::Fgfr1flox/flox (3796144, decreased by 80%), and
Fgfr1DFrs/DFrs (93677, decreased by 95%), but not in Fgfr1Y766F/Y766F
Figure 3. Cochlear hair cells are reduced in Fgfr1 mutants. (A) Schematic of whole mount view of neonatal cochlear duct. HCs are arranged
along the entire length of cochlear duct. (B) Magnified view of wild type cochlear duct labeled with anti-Myo7a antibody. Highly ordered array of
three rows of OHCs and one row of IHCs are observed. (C–E) HCs are disrupted in Six1enh21-Cre::Fgfr1flox/flox cochlea. Basally, few OHCs are visible (C).
In the middle, there are small gaps in the remaining IHCs (asterix) (D). Apically, sparsely distributed HCs are observed (E). (F–H) Emx2-Cre::Fgfr1flox/flox
mice show a less severe phenotype. Basally, IHCs and OHCs form, although only two rows of OHCs form (F). In the middle region, islands of HCs form
between gaps (asterix). Additional IHCs are occasionally observed (arrowheads) (G). Apically, islands are sparse (H). (I–K) Fgfr1DFrs/DFrs cochlea shows a
less severe phenotype than that of Six1enh21-Cre::Fgfr1flox/flox cochlea, but more severe phenotype than Emx2-Cre::Fgfr1flox/flox cochlea. Basally, some
IHCs and OHCs form, although frequently arranged in islands, punctuated by gaps (asterix). (L) The number of rows of HCs and their patterning are
unaffected in Fgfr1Y766F/Y766F mutant cochlea. (M) Stacked graph comparing the number of cochlear IHCs and OHCs amongst different Fgfr1 mutants.
Sum of each number represents total HC number. Statistic significance is shown for total HC number. Error bars (mean 6 SD) represent variation in
each HC type. (N) Graph showing relative length of cochlear duct at E18.5. Cochlear length is decreased by approximately 40–50% in all Fgfr1mutants
except Fgfr1Y766F/Y766F. (O) Number of IHCs and OHCs are counted and normalized to 100 mm from different Fgfr1 mutants. Sum of each number
represents total HC number per 100 mm. Statistic significance is shown for each HC type, compared with the number of HCs from wild type. Error bars
(mean 6 SD) represent variation in each HC type. *p,0.05. ns, not significant. Scale bar: C–L; 50 mm (in L).
doi:10.1371/journal.pgen.1004118.g003
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(1894624). With the exception of Fgfr1Y766F/Y766F mutants
(626619), the number of IHCs were also reduced in FGFR1
signaling mutants; Six1enh21-Cre::Fgfr1flox/flox (179625, decreased by
72%), Emx2-Cre::Fgfr1flox/flox (3496130, decreased by 44%), and
Fgfr1DFrs/DFrs (259661, decreased by 58%), compared with wild type
control (618631) (p,0.05). In addition, cochlear length was
decreased by 41% in Six1enh21-Cre:: Fgfr1flox/flox, by 49% in Emx2-
Cre::Fgfr1flox/flox, and by 37% in Fgfr1DFrs/DFrs mutants, respectively
(Figure 3N). To exclude the influence of cochlear length on total HC
number, we counted the number of each HC type normalized to
100 mm length (Figure 3O). IHCs were decreased (p,0.05)
by 33% in Six1enh21-Cre::Fgfr1flox/flox (6.862.1), by 17% in
Fgfr1DFrs/DFrs (860.1) of wild type levels (10.360.1). However,
normalized number of IHCs was statistically the same in Emx2-
Cre::Fgfr1flox/flox (13.464.1) and wild type (10.360.1). In contrast,
OHC number per 100 mm was decreased by 98% in Six1enh21-
Cre::Fgfr1flox/flox (0.761.2), by 56% in Emx2-Cre::Fgfr1flox/flox
(12.8611.1), and by 87% in Fgfr1DFrs/DFrs (2.062.2) when compared
to wild type levels (29.160.4). These findings suggested that
FGFR1-Frs2/3 activity was required for OHC development from
E10.5, whereas FGFR1-Frs2/3 activity was only required for IHC
development prior to E12.5. Taken together, these results
demonstrate that signalling via Frs2/3 recruitment is necessary for
FGFR1 activity during the formation of the cochlear HCs.
In addition to the cochlear HC phenotype, we analyzed the
number of HCs in one of the vestibular sense organs, the utricle
dissected from E16.5 mice. While utricilar HCs number was
comparable between Six1enh21-Cre:: Fgfr1flox/+ (577621, n = 3) and
Six1enh21-Cre:: Fgfr1flox/flox (550610, n= 4) (Figure 4A, B), HC
number was significantly decreased (p,0.05) in Fgfr1DFrs/DFrs
mutants (473657, n = 6), by comparison with Fgfr1DFrs/+ control
(718681, n = 4) (Figure 4C, D). As this mutant is non-conditional, it may
suggest that FGFR1 signalling outside of the inner ear epithelium plays a role
in vestibular HC formation.
Support cell development is perturbed in the absence of
Frs2/3-mediated FGFR1 signalling
The decision by sensory precursors to generate either HCs or
SCs is controlled by Notch-Delta cell-cell signalling [5,13–15].
Therefore, one possible mechanism of FGFR1 action is in
modifying the action of Notch and Delta in this choice. We thus
investigated whether SC formation was disrupted in the absence of
Frs2/3-mediated FGFR1 signalling. We crossed Fgfr1DFrs/DFrs onto
an Atoh1-GFP reporter line to reveal HCs. At E18.5, Prox1 is
strongly expressed in the Deiter’s cells and in the pillar cells [31].
In the control, Fgfr1DFrs/+ cochlea, Prox1-labeled 5 rows of cells
(Figure 5A). In mutant Fgfr1DFrs/DFrs cochlea, only two to three
rows of Prox1-labelled cells were detected and were confined
within sensory islands (Figure 5B). In whole mount view of
Fgfr1DFrs/+ cochlea, p75 expression was apparent in the inner pillar
cells that are found along the length of the cochlear duct
(Figure 5C). In Fgfr1DFrs/DFrs cochlea, p75 staining was only found
in the sensory cell islands highlighted by Atoh1-GFP and not
found in the intervening spaces (Figure 5D). Within severely
affected region, the row of p75-positive cells was mostly present
lateral to the one row of HCs, suggesting that these islands were
exclusively IHCs.
The other SC marker at this stage, Sox2, was also only found
within the sensory islands (Figure 5E and F). Section analysis
revealed that Sox2 is expressed in SCs, in both control organ of
Corti (Figure 5G) and in sections taken through the level of the
islands in Fgfr1DFrs/DFrs cochlea (Figure 5H). In sections taken
through the gaps in between the islands, we could only detect weak
Sox2 expression in the Ko¨lliker’s organ, a region medial to lateral
compartment (Figure 5I). Combined, these results suggest that the
FGFR1-Frs2/3 signalling axis also affects the formation of SCs,
and is thus acting upstream of HC/SC decision mediated by
Notch-Delta signalling.
FGFR1/Frs2/3 interaction is not essential for FGFR1-
mediated cell cycle regulation during inner ear
development
Precursors of auditory HCs and SCs form from a domain
known as the prosensory domain [1]. This region emerges from
within the Sox2-positive sensory patch between E12.5 and E14.5,
depending on the exact position within the cochlea. It is initially
characterised by the cessation of mitosis, forming the zone of non-
proliferating cells (ZNPC), as well as the expression of a cell cycle
inhibitor, p27Kip1. Subsequently, the ZNPC expresses specific
markers of the prosensory domain such as Hey2 and Hes5. It had
been previously shown that a conditional deletion of Fgfr1
regulates proliferation in the cochlea [20]. We thus asked if cell
cycle regulation within the cochlea was mediated by FGFR1-
mediated Frs2/3 activity.
We first asked if Six1enh21-Cre:: Fgfr1flox/flox mutants used in this
study recapitulated the reported cell cycle deficit shown previously
in FoxG1-Cre:: Fgfr1flox/flox [20]. Prosensory domain progenitors
become post-mitotic commencing at the apex at E12.5 and ending
at the base at E14.5. Cell cycle exit correlates with the expression
of p27Kip1, as was observed in whole mount preparations of
control heterozygous cochlea stained for p27Kip1 and BrdU
(Figure 6A and B). Consistent with previous observations, no cell
cycle defect was detected in Six1enh21-Cre:: Fgfr1flox/flox mutant at
E10.5 (data not shown) [20]. However, a reduction in cell
proliferation within the epithelial cells of the cochlea was detected
Figure 4. Disruption of FGFR1-Frs2/3 pathway decreases the
number of vestibular hair cells. (A, B) No change in HC number was
detected between E16.5 Six1enh21-Cre::Fgfr1flox/+ (A) and Six1enh21-
Cre::Fgfr1flox/flox utricles (B) labeled with anti-Myo7a antibody. (C, D)
Fewer HCs were observed in the utricle of E16.5 Fgfr1DFrs/DFrs mutants
(D) than Fgfr1DFrs/+ control (C). Ampullary HCs are also included
(asterisks). Scale bar: A–D; 200 mm (in D).
doi:10.1371/journal.pgen.1004118.g004
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in Six1enh21-Cre:: Fgfr1flox/flox mice at E12.5 (Figure 6C). This
phenotype was more prominent in Ko¨lliker’s organ at E13.5 and
E14.5. Surprisingly, and despite the proper formation of the
ZNPC, p27Kip1 was down-regulated in Six1enh21-Cre:: Fgfr1flox/flox
cochleae at E13.5 and E14.5 when compared to controls
(Figure 6D). Quantification of BrdU-labelled cells showed far
fewer proliferating cells in E12.5 nascent cochlear duct of
Six1enh21-Cre:: Fgfr1flox/flox (1468: n= 5 compared with 4168:
n = 4 in wild type controls) and E14.5 Ko¨lliker’s organ (262: n = 5
compared with 2164: n= 5 in wild type controls) (p,0.05)
(Figure 6G).
We next investigated proliferation in Fgfr1DFrs/DFrs cochlea.
Fgfr1DFrs/DFrs mutant cochleae still exhibited down-regulation
of p27Kip1 throughout cochlear duct (Figure 6F). However in
Figure 5. Disruption of FGFR1-Frs2/3 pathway decreases the number of support cells. (A) Prox1 immunostaining (magenta) marks
cochlear SCs; the pillar cells and Deiter’s cells in heterozygous Fgfr1DFrs/+ cochlea at E18.5. This line also expresses GFP under the control of the Atoh1
enhancer marking HCs (green). (B) In mutant Fgfr1DFrs/DFrs cochlea, HCs form Atoh1-GFP-positive sensory islands. Prox1-positive SCs are not detected
in the space between these islands. (C) In Fgfr1DFrs/+ control cochlea at E18.5, expression of p75 (magenta), a marker for pillar cells, marks adjacent to
the IHCs. (D) p75 is observed in patches in mutant Fgfr1DFrs/DFrs cochlea (arrowheads), and it is not detected in the gaps between islands. Note that
most Atoh1-GFP-positive HCs are located medial to p75-expressing pillar cells. (E) In heterozygous Fgfr1DFrs/+ cochlea at E18.5, Sox2 (magenta) marks
SCs arranged in rows coincident with Atoh1-GFP-positive HCs. (F) In mutant Fgfr1DFrs/DFrs cochlea, Sox2 expression extends beyond the sensory
islands, but is not detected in the gaps (arrows). (G) Transverse section view of organ of Corti from E18.5 Fgfr1DFrs/+ expressing GFP under the control
of the Atoh1 enhancer, labeled with Sox2. One IHC (arrow) and three OHCs (bracket) are observed. Sox2 is expressed in surrounding SCs, including
Deiter’s cells, pillar cells, inner phalangeal cell, and Ko¨lliker’s organ. (H) Cross section of a sensory island from E18.5 mutant Fgfr1DFrs/DFrs cochlea. Here,
one IHC (arrow) and two OHCs (bracket) are detected. Sox2 expression is detected in surrounding SCs. (I) Cross section of a gap intervening sensory
islands from mutant Fgfr1DFrs/DFrs cochlea. No HCs are detected and Sox2 is only detectable in Ko¨lliker’s organ, but not in lateral compartment
(bracket). Nuclei are visualized by DAPI. Scale bars: A–F, 50 mm in (in F); G–I, 30 mm (in I).
doi:10.1371/journal.pgen.1004118.g005
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contrast to Six1enh21-Cre:: Fgfr1flox/flox mutant cochlea, BrdU-
positive cells were observed in Ko¨lliker’s organ of Fgfr1DFrs/DFrs
mutant (Figure 6E). Comparable number of BrdU-positive cells
were detected in Fgfr1DFrs/DFrs at both stages (3668: n= 4 at E12.5,
and 2165: n= 5 at E14.5) (p,0.05) (Figure 6G). We also quantified
the number of BrdU-positive cells in Emx2-Cre::Fgfr1flox/flox cohleae.
Reduced proliferation was only detected at E14.5 and was milder
than that observed for Six1enh21-Cre:: Fgfr1flox/flox (3961: n= 4
at E12.5, and 961: n= 4 at E14.5). These results indicate that
Frs2/3 recruitment does not mediate FGFR1-induced cell prolif-
eration in Ko¨lliker’s organ during inner ear development.
Furthermore, these results showed that FGFR1-Frs2/3 signaling
is not necessary for the formation of the ZNPC, but is required for
p27Kip1 expression.
Figure 6. FGFR1-mediated cell proliferation is not mediated by Frs2/3 interaction. Cochlear whole mounts from controls (A, B), Six1enh21-
Cre::Fgfr1flox/flox (C, D) and Fgfr1DFrs/DFrs (E, F) were assessed for incorporation of BrdU injected 2 hours before sacrifice (A, C, E) and the expression of
p27Kip1 (B, D, F) at E12.5, E13.5, and E14.5. (A) The pattern of BrdU uptake indicates that the ZNPC (circled by dotted line) is first apparent at E12.5 in
the apex of control cochlea and extends basally by E14.5 in control cochlea. At E13.5 and E14.5, proliferation in Ko¨lliker’s organ medial to the ZNPC is
apparent. (B) p27Kip1 protein expression is co-incident with the ZNPC in control cochlea at E12.5 to E14.5. (C) The ZNPC was still detected in
Six1enh21-Cre::Fgfr1flox/flox cochlea apically at E12.5, extending basally by E14.5. Reduced BrdU uptake was noted in Ko¨lliker’s organ. (D) p27Kip1
protein expression in apical region was normal at E12.5, but reduced in Six1enh21-Cre::Fgfr1flox/flox cochlea at E13.5 and E14.5. (E) BrdU
immunostaining revealed that the ZNPC also formed normally in Fgfr1DFrs/DFrs cochlea from E12.5. However, robust proliferation was noted in
Ko¨lliker’s organ at E13.5 and E14.5. (F) p27Kip1 protein expression in apical region was normal at E12.5, but reduced in Fgfr1DFrs/DFrs cochlea at E13.5
and E14.5, compared to control. (G) Graph showing the number of BrdU-positive cells at in the cochlea at E12.5 and in Ko¨lliker’s organ at E14.5. BrdU-
labelled cells were reduced in Six1enh21-Cre:: Fgfr1flox/flox cochleae at both E12.5 and E14.5. In Emx2-Cre::Fgfr1flox/flox mutant cochlea, there was no
significant reduction in proliferation at E12.5, but a reduction in BrdU uptake was noted in Ko¨lliker’s organ at E14.5. No difference was detected
between control and Fgfr1DFrs/DFrs cochlea. *p,0.05. Scale bar: 75 mm.
doi:10.1371/journal.pgen.1004118.g006
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Formation of the prosensory domain is disrupted by lack
of FGFR1-Frs2/3 signalling
The down-regulation of p27Kip1 expression in the prosensory
domain indicated that even though prosensory precursors had
become post-mitotic, a marker of the prosensory domain was not
correctly expressed. Section analysis revealed that as well as
p27Kip1 (Figure 7A–C), the prosensory domain marker Hey2 was
also reduced in cochlea from both Six1enh21-Cre::Fgfr1flox/flox and
Fgfr1DFrs/DFrs mutants (Figure 7D–F). We confirmed the down-
regulation of p27Kip1 and Hey2, as well as two other prosensory
markers, Hes5 and Atoh1, by quantitative PCR (Figure 7P). The
down-regulation of prosensory domain markers was significantly
milder in Emx2-Cre::Fgfr1flox/flox cochleae than in either Six1enh21-
Cre::Fgfr1flox/flox or Fgfr1DFrs/DFrs mutants (Figure 7P).
As well as the prosensory domain, the Sox2-positive sensory
patch also forms Ko¨lliker’s organ and the outer sulcus. We thus
asked if Fgfr1 mutation also affected these structures. Cells in
Ko¨lliker’s organ normally express Fgf10 and Jag1. In both
Six1enh21-Cre::Fgfr1flox/flox and Fgfr1DFrs/DFrs mutants, the spatial
expression of Jag1 (Figure 7G–I) and Fgf10 (Figure 7J–L) was
unchanged. However, quantitative PCR revealed a down-regula-
tion of Fgf10 expression, although Jag1 did not show any significant
difference (Figure 7P). The spatial pattern of Bmp4, a marker for the
outer sulcus located lateral to prosensory domain, was also
unchanged in Six1enh21-Cre::Fgfr1flox/flox and Fgfr1DFrs/DFrs mutants
(Figure 7M–O). Quantitation revealed up-regulation of Bmp4 only
in Six1enh21-Cre::Fgfr1flox/flox mutant but not in Fgfr1DFrs/DFrs
(Figure 7P). These results indicate that although cell cycle exit, an
aspect of prosensory domain induction, occured normally, the
induction of genes marking the prosensory domain is impaired in
the absence of Frs2/3-mediated FGFR1 signalling. This signalling
also contributes to the up-regulation of Fgf10 in Ko¨lliker’s organ.
However, FGFR1 signalling independently of Frs2/3 recruitment,
may negatively regulate Bmp4 expression in the outer sulcus.
FGFR1 is necessary for Sox2 maintenance during sensory
patch formation
The expression of Sox2 in the sensory patch is known to be
critical in the formation of prosensory domain and subsequent HC
formation; mutation or reduction in Sox2 expression affects their
development in a dose-dependant fashion [2]. Furthermore, FGF
signalling has been shown to be sufficient for Sox2 expression [22].
We thus hypothesised that the HC phenotype observed in Fgfr1
mutants were, in part, due to alterations in Sox2 expression.
Initially, Sox2 is expressed in the neuronal and sensory precursors
in the otocyst at E10.5. Between E12.5 to E14.5, Sox2 expression
in the cochlear duct is detected in the thickened epithelial cells that
mark the site of the prosensory domain [32]. By E18.5, Sox2 is
confined to the SCs of the organ of Corti [4].
Sox2 was initially expressed at comparable levels between
control, heterozygous, inner ears and Six1enh21-Cre::Fgfr1flox/flox
mutants at E10.5 (Figure 8A and B). By E11.5, expression in
Six1enh21-Cre::Fgfr1flox/flox inner ears was decreased (Figure 8D),
although in Fgfr1DFrs/DFrs expression levels were equivalent to those
in control inner ears (Figure 8C and E). By E12.5, decreased
expression of Sox2 in the cochlea of both Fgfr1 mutant lines was
apparent (Figure 8F–H), although Sox2 expression in the saccule
was unchanged. To quantify this decrease, we measured Sox2
protein levels in E12.5 mouse cochlea. Levels were reduced by
approximately 78% in Six1enh21-Cre::Fgfr1flox/flox to the levels found
in Six1enh21-Cre::Fgfr1flox/+, while a 55% decrease was observed in
Fgfr1DFrs/DFrs when compared to heterozygous controls (Figure 9A).
This down-regulation was confirmed by immunostaining whole
cochleae with Sox2 antibody (Figure 9B and C). To exclude the
possibility that the early Sox2 down-regulation occurred due to
accelerated prosensory domain development, we used BrdU uptake
to indicate its formation. At E12.5, even though Sox2 is down-
regulated in the cochlear rudiment of Six1enh21-Cre::Fgfr1flox/flox,
BrdU-positive cells can still be detected (Figure 9D and E),
indicating that Sox2 down-regulation occured prior to prosensory
domain formation. Furthermore, the down-regulation is not a result
of cell survival: No difference in cell death was observed between
controls and Six1enh21-Cre::Fgfr1flox/flox cochleae using an antibody
against activated caspase-3 to detect apoptotic cells (data not
shown).
At E14.5, the onset of sensory cell differentiation, Sox2 is
expressed robustly in the prosensory domain (Figure 10A).
Six1enh21-Cre::Fgfr1flox/flox (Figure 10B) and Fgfr1DFrs/DFrs cochleae
(Figure 10C) showed weak Sox2 expression in prosensory domain.
When compared to E14.5 heterozygous controls, Sox2 expression
was decreased by approximately 66% in Six1enh21-Cre::Fgfr1flox/flox
mutant cochlea, and by 49% in Fgfr1DFrs/DFrs. Only a 12%
decrease of Sox2 expression levels was observed in Emx2-
Cre::Fgfr1flox/flox mutants (Figure 10D). To exclude the possibility
that reduced Sox2 expression was as a result of reduced cell
numbers, Sox2-positive cells in the prosensory domain were
counted (Figure 10E). No significant difference between controls
(19.861.5: n = 5) and both Six1enh21-Cre::Fgfr1flox/flox (1861.0:
n = 4) and Fgfr1DFrs/DFrs (21.661.5: n= 4) cochleae was detected.
These results indicate that reduced expression of Sox2 is
independent of cell number. In addition, reduced Sox2 expression
was also detected in SCs of E18.5 Fgfr1DFrs/DFrs cochlea
(Figure 5G–I).
Sox2 expression in the sensory patch is induced by activation of
the Notch receptor by its ligand Jag1 [6,14]. Expression analysis of
Jag1 in Six1enh21-Cre::Fgfr1flox/flox mutant revealed that its expres-
sion pattern is unchanged (Figure 11A and B), suggesting that
FGFR1 signalling affects Sox2 expression independent of any
affect on Jag1 regulation. Taken together, we suggest that FGFR1-
Frs2/3 signalling is required for Sox2 maintenance in sensory
progenitors.
ERK phosphorylation is repressed in the inner ear of
FGFR1 signalling mutants
Frs2/3-mediated FGFR1 signalling is transduced by a number
of downstream pathways. We investigated which were activated
during Sox2 maintenance in the sensory patch. The MAP kinase
pathway is one of the key mediators of receptor tyrosine kinase
signalling, and is activated through Frs2/3 recruitment to FGFR1
[25]. To determine if this pathway was activated in the inner ear,
we used antibodies specific for the di-phosphorylated form of Erk1
and Erk2 (dpERK), an indicator of MAPK activity [33], to
investigate the spatiotemporal activation of this pathway in the
inner ear.
Our data thus far suggested that FGFR1 activity commencing
prior to E12.5 and was necessary for Sox2 maintenance. In
agreement with this timing, we detected ventral localization of
dpErk in the otocyst of E10.5 Fgfr1DFrs/+ heterozygous embryos
(Figure 12A). In contrast, otocyst expression could not be detected
in homozygous Fgfr1DFrs/DFrs embryos (Figure 12B). At E11.5,
sections revealed ventromedial dpErk localization in the otocyst of
Six1enh21-Cre::Fgfr1flox/+ heterozygous control (Figure 12C) but is
down-regulated in both homozygous Six1enh21-Cre::Fgfr1flox/flox
otocyst as well as Fgfr1DFrs/DFrs homozygote embryo (Figure 12D
and E). Frs2/3-mediated FGFR1 signalling also activates PI3K,
which results in the phosphorylation of Akt [26]. We thus asked if
this pathway was also affected in FGFR1 signalling mutants. At
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Figure 7. FGFR1-Frs2/3 pathway is required for the specification of prosensory domain. (A–C) p27Kip1 (magenta) is expressed in the post-mitotic,
BrdU (green) negative, prosensory domain (bracket) in sections of E14.5 cochlea (A). Expression of p27Kip1 is decreased in Six1enh21-Cre:: Fgfr1flox/flox cochlea (B)
and in Fgfr1DFrs/DFrs cochlea (C). (D–F) Hey2 (magenta) is expressed in the prosensory domain (brackets) in sections of E14.5 cochlea (counter-stained with
phalloidin: green) (D). Hey2 expression is down-regulated in both Six1enh21-Cre:: Fgfr1flox/flox mutant cochlea (E) and Fgfr1DFrs/DFrs (F). (G–I) Section of control
E14.5 cochlea shows Jag1 immuno-labelling in Ko¨lliker’s organ. (G). Expression is unchanged in both Six1enh21-Cre::Fgfr1flox/flox (H) and Fgfr1DFrs/DFrs (I). (J–L) In
situ hybridization of Fgf10 on section of E14.5 cochlea shows expression in Ko¨lliker’s organ (J). While the expression pattern is unchanged, Fgf10 expression
levels are lower in Six1enh21-Cre::Fgfr1flox/flox cochlea (K). Expression in Fgfr1DFrs/DFrs mutant cochlea is unchanged (L). (M–O) Bmp4 expression in E14.5 control
cochlea is restricted to the outer sulcus (M). The expression pattern is unchanged, however Bmp4 expression levels are higher in Six1enh21-Cre::Fgfr1flox/flox
cochlea (N). Expression in Fgfr1DFrs/DFrs mutant cochlea is unchanged (O). (P) Quantification of relative mRNA level of Atoh1, Hes5, p27Kip1, Hey2, Fgf10, Jag1 and
Bmp4 in E14.5 cochlear epithelial cells using quantitative PCR. Mean 6 SD are shown. *p,0.05. l, lateral; d, dorsal. Scale bar: A–O, 75 mm (in C).
doi:10.1371/journal.pgen.1004118.g007
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E12.5 we found no difference in the levels of phospho-Akt between
Six1enh21-Cre::Fgfr1flox/+ heterozygous and Six1enh21-Cre::Fgfr1flox/
flox otocysts (Figure 12F).
At later stages of sensory cell development, FGF8 signalling
mediated through FGFR3 is thought to play a role in the
specification of pillar and Deiter’s cells [34,35]. To verify the
specificity of the FGFR1 signalling mutants, we asked if ERK
phosphorylation was affected at these later stages. We found no
obvious difference in dpErk localization to the cells of E14.5
Six1enh21-Cre::Fgfr1flox/+ heterozygous and Six1enh21-Cre::Fgfr1flox/
flox homozygous inner ears (Figure 12G and H), where nascent
pillar cells IHCs are present. Thus, inhibition of signalling by
FGFR1 specifically affects early ERK phosphorylation at E10.5
and E11.5, but does not affect later activation at E14.5 by other
FGF receptors.
Discussion
Formation of cochlear HCs takes place progressively, with the
potential of a group of Sox2-positive precursor cells, known as the
sensory patch, becoming gradually restricted under the influence
of a number of signalling molecules. Our observations suggest that
FGFR1 signalling, acting through the adaptor Frs2/3, is
responsible for sensory progenitor maintenance, partly through
the maintenance of early Sox2 expression, and that in its absence,
down-regulation of Sox2 results in a reduction in the number of
HCs. However, despite the reduction of early Sox2 expression,
subsequent patterning of the sensory patch into the precursor
domain of the sensory cells, the prosensory domain, is only
partially affected. Surprisingly, even though prosensory domain
markers such as p27Kip1 and Hey2 are dramatically down-
regulated in both the conditional Six1enh21-Cre::Fgfr1flox/flox and
Fgfr1DFrs/DFrs allele, a ZNPC is still established normally, and on
schedule, showing the normal apical to basal progression. This also
implies that the cell cycle inhibitor p27Kip1 is required redundantly
for sensory progenitors to exit the cell cycle exit. In the mouse, the
cell cycle inhibitor p19Ink4d is also found in the sensory
progenitors, and is known to act redundantly with p27Kip1 [36].
FGF signalling regulates Sox2 maintenance in the
sensory patch
The regulation of Sox2 by FGF signaling has been characterized
in a number of other systems, for example during foregut
development [37], retinal pigmented epithelia [38], the lens placode
[39] and in the differentiation of osteoblasts [40]. We show that in
the cochlear precursor, FGF signalling maintains Sox2 expression.
Figure 8. Sox2 is not maintained in FGFR1 signalling mutants.
(A, B) Sox2 protein expression in sections of control E10.5 otocyst (A) is
comparable to the expression observed in E10.5 Six1enh21-Cre::Fgfr1flox/flox
otocyst (B). (C–E) At E11.5, Sox2 expression is detected in the control
otocysts (C), but is down-regulated in Six1enh21-Cre::Fgfr1flox/flox otocyst
sections (D). In Fgfr1DFrs/DFrs otocyst, expression is slightly down-regulated,
although the morphology of the otocyst is closer to E10.5 (E). (F–H) By
E12.5, the cochlear duct expression of Sox2 is apparent in control inner
ears (F), however Sox2 is down-regulated in Six1enh21-Cre::Fgfr1flox/flox
mutants (G) and Fgfr1DFrs/DFrs inner ears (H) (within dotted lines). By
contrast, Sox2 expression in saccular epithelium is unaffected in both
mutants. m, medial; p, posterior; cd, cochlear duct. Scale bars: A–E; 75 mm
(in E), F–H; 150 mm (in H).
doi:10.1371/journal.pgen.1004118.g008
Figure 9. Sox2 is down-regulated prior to prosensory domain
formation in FGFR1 signalling mutants. (A) Western blotting of
cochlear lysates at E12.5 shows Sox2 protein in heterozygous
Six1enh21-Cre::Fgfr1flox/+ (lane 1), mutant Six1enh21-Cre::Fgfr1flox/flox (lane
2) or heterozygous Fgfr1DFrs/+ (lane 3), and mutant Fgfr1DFrs/DFrs (lane 4).
Sox2 is decreased in both FGFR1 signalling mutants compared to
control. ß-actin is used as a loading control. (B, C) Whole-mount cochlea
at E12.5 show normal Sox2 expression in heterozygous controls (B),
however Sox2 is down-regulated in Six1enh21-Cre::Fgfr1flox/flox cochlea
(C). (D, E) BrdU-positive cells are present along the width of cochlear
duct of control (D) and Six1enh21-Cre::Fgfr1flox/flox (E) (within dotted
lines) although Sox2 immunoreactivity is decreased in the mutant
cochlea. Scale bar: D, E, 75 mm (in E).
doi:10.1371/journal.pgen.1004118.g009
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The reduction of Sox2 is not as a consequence of reduced
proliferation (and hence reduced numbers) of Sox2-positive cells.
While the number of proliferating cells in Six1enh21-Cre::Fgfr1flox/flox
cochlea is reduced, the numbers in the Fgfr1DFrs/DFrs allele are not.
Despite this difference, Sox2 levels are reduced in both mutants at
E12.5 and E14.5, suggesting that during cochlear HC formation
one role for FGFR1 signaling is in the maintenance of Sox2
expression. Further support for the regulation of Sox2 by FGFR1
signaling comes from the correspondence of HC loss seen in
Six1enh21-Cre::Fgfr1flox/flox and Fgfr1DFrs/DFrs cochlea with other
mutants. Sensory cell loss is more prominent apically in the cochlea,
with the phenotype becoming milder basally. Such phenotypes are
similar to knockouts or hypomorphic alleles of Jag1 and Sox2 [2,6],
suggesting their involvement in a gene network with Fgfr1. Indeed
further support for this molecular network comes from explant
studies that show that exogenous application of FGF20 can
overcome Notch-Jagged-mediated inhibition of Sox2 [22]. One
caveat is that it is unclear whether the regulation of Sox2
maintenance by FGFR1 signalling is direct or indirect, through
the upstream regulation of other factors important in Sox2
maintenance. It is clear that further studies are necessary to
determine the exact mechanism by which FGFR1 signalling
regulates Sox2.
At least two roles for Sox2 have been described during the
formation of the cochlear sensory cells. The above-mentioned
network, apparent from E10.5 to E12.5, maintains the compe-
tence of precursor cells to form sensory progenitors. This is
supported by the analysis of the cochlear phenotype of mutant
mice with little or no Sox2. These mutants show reduced, or
absent HCs in the cochlea [2]. A later role for Sox2, from around
E15, has been proposed. Here, Sox2 maintains SC fate, and
preventing ectopic HC formation through the repression of Atoh1
[4]. This is suggested by hypomorphic alleles where the reduction
of Sox2 is not as severe. Here, HC number is increased [2,4]. Our
results suggest that these two activities are separable, with FGFR1
signalling maintaining sensory commitment, partly through Sox2
regulation.
The question remains, how does decreased Sox2 as a result of
reduced FGFR1 signalling translate into reduced sensory cells in
the cochlea? Sox2 expression as well as other prosensory markers
expressed in prosensory domain were down-regulated in both
Six1enh21-Cre::Fgfr1flox/flox and Fgfr1DFrs/DFrs mutants, whereas only
Six1enh21-Cre::Fgfr1flox/flox mutants showed defect in cell prolifera-
tion. Moreover, both mutants showed similar effects on the
formation of HCs. We thus conclude that early cell cycle exit
provides, at most, a minor contribution to the disruption of
prosensory formation, and hence cochlear HC development in
FGFR1 signalling mutants. Instead, it is possible that the level or
duration of Sox2 expression determines the commitment or
competence to form HCs. A number of studies have described the
quantitative requirement for Sox2 in other systems such as in the
retinal progenitors [41], anterior foregut [37] and in taste buds [42].
Indeed, over-expression studies have suggested this is also the case in
HC [4]. One possible mechanism, through which the duration of
Sox2 expression in progenitors and precursors may be translated into
effects on commitment and differentiation, is suggested fromwork on
the effects of Sox2 binding to target gene enhancers in other systems
[43,44]. Here silenced genes, important for cell type differentiation,
are pre-bound with Sox2. Pre-binding is thought to be associated
with the generation of local epigenetic changes [44] or is required for
successive binding of co-operative factors [43], important in gene
activation, priming the genes for activation. Consistent with this is
data showing Sox2 binding sites in the Atoh1, a gene that is
responsible for sensory cell differentiation in the inner ear [45].
Similarly, we suggest that one function of maintained early Sox2
expression, controlled by FGFR1 signalling, is to prime prosensory
genes, such as Atoh1, for subsequent activation and thus control the
differentiation of the sensory cells.
The disruption of the transition from Sox2-positive sensory
progenitors to prosensory precursors also provides an explanation
for the discontinuous ‘‘island’’ phenotype of HCs in the cochlea of
FGFR1 signalling mutants. Convergent extension movements that
Figure 10. Sox2 is weakly expressed in FGFR1 signalling
mutants at the onset of sensory cell differentiation. (A–C) At
E14.5, Sox2 expression can be detected in the prosensory domain of
control cochlear duct sections (A), but is down-regulated in Six1enh21-
Cre::Fgfr1flox/flox inner ear (B) and Fgfr1DFrs/DFrs inner ears (C) (brackets).
(D) Quantification of relative mRNA level of Sox2 in E14.5 cochlear
epithelial cells using quantitative PCR. Mean 6 SD are shown. *p,0.05.
(E) The number of Sox2-positive cells from the middle turn of cochlear
duct were counted. Mean6 SD are shown. Scale bar: A–C; 75 mm (in C).
doi:10.1371/journal.pgen.1004118.g010
Figure 11. Sox2 down-regulation is independent of Jag1
action. (A, B) Expression of Jag1, the Notch ligand important for Sox2
expression, is unaffected in control (A) and Six1enh21-Cre::Fgfr1flox/flox
cochlea (B) at E12.5. Scale bar: A, B, 75 mm in (B).
doi:10.1371/journal.pgen.1004118.g011
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partially drive cochlear extension normally distribute sensory
precursors over the length of the organ of Corti [46,47]. However
the fewer numbers of precursors in FGFR1 signalling mutants
cannot be evenly dispersed. The apical to basal difference in the
distribution of the sensory cells in these mutants may suggest
directionality for these rearrangements.
FGFR1 signalling and inner ear hair cell development
Several studies have proposed FGF20 as the FGFR1 ligand
during mouse cochlear development [21,48]. Indeed there is good
correlation of the phenotype between Fgf202/2 mutants and
Emx2-Cre::Fgfr1flox/flox described in this study; both have moderate
reduction in the number of OHC, and IHC remains unaffected. In
addition, their prosensory domain formation is largely unaffected.
In contrast, there are important differences between Fgf20 nulls
and both Six1enh21-Cre::Fgfr1flox/flox and Fgfr1DFrs/DFrs mutants. In
these more severe Fgfr1 mutants, HC number is more severely
reduced and IHC are also affected. Analysis of Fgf20 nulls revealed
a function for Fgf20 in HC differentiation since undifferentiated
Sox2-positive cells between sensory islands have been reported [21].
In Fgfr1DFrs/DFrs mutant cochleae, however, there are no Sox2-
positive cells detected in the lateral compartment among the HC
islands. Furthermore, and in contrast to Fgf202/2 mutant cochlea,
Sox2 is down-regulated in both Six1enh21-Cre::Fgfr1flox/flox and
Fgfr1DFrs/DFrs mutants from E12.5 to at least E14.5, and prosensory
domain formation is disrupted. Our use of the two Cre drivers
suggests a reason for this discrepancy. We propose that the FGFR1
has at least two distinct functions in auditory HC development. An
early role, prior to E13.5, is in the maintenance of prosensory
function, in part through the regulation of Sox2, and in the
Figure 12. ERK phosphorylation is inhibited in the developing inner ear of FGFR1 signalling mutants. (A, B) Immunostaining for dpERK
in E10.5 whole embryos, reveals ERK phosphorylation in the ventral half of the Fgfr1DFrs/+ otic vesicle (arrow, and inset for magnified image) (A). ERK
phosphorylation is undetectable in mutant Fgfr1DFrs/DFrs otocyst (arrow, and inset for magnified image) (B). For internal control, dpERK localization to
rostral edge of PA1 and caudal edge of PA2 is detected in both heterozygotes and homozygotes. (C–E) dpERK immuno-labelling on coronal sections
of E11.5 mouse heads. dpERK staining can be detected in the ventromedial wall of the control otocyst (C), but is undetectable in Six1enh21-
Cre::Fgfr1flox/flox (D) and Fgfr1DFrs/DFrs otocysts (E) (dashed lines). (F) Western blotting was used to detect phosphorylated and unphosphorylated forms
of Akt in protein extracted from E12.5 cochlear epithelia. The level of phosphorylated Akt was unchanged between Six1enh21-Cre::Fgfr1flox/+ and
Six1enh21-Cre::Fgfr1flox/flox cochlea. (G, H) Immuno-labeling of cross sections of the cochlear duct of E14.5 mice with the dpERK and p27Kip1 antibodies.
In both Six1enh21-Cre::Fgfr1flox/+ (G) and Six1enh21-Cre::Fgfr1flox/flox (H), the domain of dpERK (magenta) is localized to the medial border of prosensory
domain marked by p27Kip1 (green) expression (arrows), where nascent IHC and inner pillar cells are present. m, medial; d, dorsal; ov, otic vesicle, pa,
pharyngeal arch; lb, limb bud. Scale bars: C–E, 50 mm (in E); G, H, 75 mm (in H).
doi:10.1371/journal.pgen.1004118.g012
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development of IHC. A later role, in OHC development, is
demonstrated by the use of Emx2-Cre, which only reaches the same
level of driver activity as Six1enh21-Cre at E14.5. Here, Sox2 expression
in prosensory domain is not severely affected despite significant
reduction in OHC numbers. This suggests that a second Fgf ligand,
operating either earlier or in combination with Fgf20, is required for
the maintenance of Sox2. Although Fgf20 is expressed in the sensory
patches from E10.5 to E14.5 [21,22], it is likely that prosensory
development, but not OHC development, could be compensated by
the second ligand in Fgf202/2 mutant cochlea. A number of Fgf
ligands are expressed in the inner ear at these stages of development.
Fgf3, -4, -5, -9, -10, -16, as well as Fgf20 are all detected in the
mammalian inner ear at early stages [21,48–54]. Receptor specificity
can be used to narrow down the likely early ligand for FGFR1. It is
known that mutation of the Fgfr1-IIIb isoform does not affect inner ear
development, thus it is likely that the Fgfr1-IIIc isoform is operating in
the sensory epithelium [20]. Of these 7 ligands, FGF4, -5, -9, -16, and
FGF20 can bind and signal through FGFR1-IIIc [55,56], suggesting
that one or more of these FGF molecules may act with FGF20 to
maintain early Sox2 expression.
FGF signalling triggers a downstream response, transducing
external cues into an internal response. We find that in the absence
of Fgfr1, or Frs2/3-mediated FGFR1 signalling, MAP kinase
phosphorylation is attenuated, suggesting that this pathway is
necessary for sensory progenitor maintenance. The similarity of
the Six1enh21-Cre::Fgfr1flox/flox phenotype with that of Fgfr1DFrs/DFrs
suggests that adaptor proteins Frs2/3 transduce the FGF signal
during sensory progenitor maintenance. However there is an
important difference between the two mutants. The defect in
proliferation seen in Six1enh21-Cre::Fgfr1flox/flox (and previously in
Foxg1-Cre::Fgfr1flox/flox [20]) is rescued in Fgfr1DFrs/DFrs. This suggests
the involvement of another downstream pathway in control
proliferation in the cochlea. Indeed, the recovery of cell cycle
impairment in Fgfr1DFrs/DFrs is consistent with previous findings
that cell lines obtained from Fgfr1DFrs/DFrs are still capable of
proliferating [28]. It is likely that other binding partners of
FGFR1, such as Grb14, Crk, and Shc, which are known to
regulate FGFR1-dependent cell proliferation may respond to
mitogenic stimulation in the developing cochlea [57–59]. In
contrast to the Fgfr1DFrs/DFrs, which lacks the Frs2/3 interaction
motif on FGFR1, mice carrying a point mutation in tyrosine at
position 766, Fgfr1Y766F/Y766F mice, showed no defect in inner ear
development. Previous reports have suggested that Y766 phos-
phorylation may act to negatively regulate FGFR1 activity [30]. It
is likely that FGFR1 activity is up-regulated in the inner ear of
Fgfr1Y766F/Y766F mutants. Given that previous studies have
suggested that exogenous FGF ligands do not result in an obvious
phenotype in the normal mouse cochlea [21], our observation of a
normal cochlea in Fgfr1Y766F/Y766F mice is not unreasonable.
Our analysis of a mutant of Frs2 in which its subsequent binding
to Shp2 is impaired (Frs2a/2F) revealed a very early defect in inner
ear development, with the inner ear arrested at the otocyst stage
(unpublished observations). This phenotype is more reminiscent of
the Fgfr2(IIIb) mutant, which is thought to mediate signalling from
Fgf3 and Fgf10 during inner ear induction [60]. This indicates that
Frs2/3-mediated FGFR signalling, like FGF signalling itself, is re-
iteratively employed during inner ear formation.
Materials and Methods
Ethics statement
Experiments were conducted and mice were housed, in
accordance with local (RIKEN CDB) and national guidelines for
animal experiments.
Generation of Six1enh21-Cre mice
Full details of the construction of Six1enh21-Cre mice will be
presented elsewhere (S. S and K. K., in preparation). Briefly, a
transgene was constructed in which the otic/epibranchial progen-
itor domain (OEPD) enhancer of the Six1 homeobox gene
(Six1enh21) [61] was placed upstream of Cre recombinase.
Transgenic males were crossed with Rosa26-flox-STOP-flox-eYFP
reporter females [62] and embryos were collected at stages E8.5 to
E11.5, LacZ expression was found in the otic/epibranchial
progenitor domain (OEPD) as early as E8.5. At subsequent stages
(E9.5 to E11.5), LacZ expression was detected in the otic vesicle
and epibranchial placodes/ganglia, scattered cells in the epibran-
chial ectoderm, the pharyngeal pouch endoderm as well as the
olfactory placode/epithelium. The transgenic mouse line, mSix1-
21-NLSCre (Acc. No. CDB0466T: http://www.cdb.riken.jp/arg/
TG%20mutant%20mice%20list.html), and is available from the
RIKEN BioResource Center (BRC).
Mice
Mice were housed in accordance with local and national
guidelines for animal experiments. The Fgfr1flox mutant mice have
been described previously [20]. Fgfr1Y766F mice were generated by
crossing Fgfr1n15YF with the ubiquitously expressed Cre from EIIa-
Cre [30]. Fgfr1DFrs mice have been previously described [28]. The
Rosa26-flox-STOP-flox-eYFP was obtained from Jackson Laboratory
(Bar Harbor, ME). The Atoh1-GFP line was provided by Dr. Jane
Johnson [63]. Emx2-Cre mice were provided by Dr. Shinichi
Aizawa [64]. FoxG1-Cre mice were provided by Jean Herbert, via
Carina Hanashima [65]. Frs2a2F/2F were as described previously
[66].
Immunohistochemistry and histology
Staged mouse heads were fixed in 4% paraformaldehyde for 1–
4.5 hours, depending on stage, and then prepared and mounted
for cryo-sectioning. Immunofluorescence was performed as has
previously been described [67]. The following antibodies were
used: anti-p27Kip1 (#RB-006-P, Thermo Scientific, Fremont, CA),
anti-Sox2 (#AB5603, Millipore, Temecula, CA), anti-pErk1/2
(#4370, Cell Signalling, Beverly, MA), anti-Hey2 (gifted by Neil
Segil, House Ear Institute, Los Angeles, USA), anti-Prox1
(#AB5475, Millipore, Temecula, CA), anti-p75 (#AB1554,
Millipore, Temecula, CA), anti-BrdU (#555627, BD Pharmingen,
Franklin Lakes, NJ), anti- Jag1 (#sc-6011, Santa Cruz Biotech-
nology, Santa Cruz, CA), anti-GFP (#04406-26. Nacalai Tesque),
anti-Caspase-3 (#G748A, Promega, Madison, WI), and anti-
Myosin7a (#25-6790, Proteus, Ramona, CA). For BrdU staining,
the specimens were pre-treated in 2N HCl for 20 min at 37uC,
and neutralized with 0.01M PBS (pH 8.5) for 10 min at room
temperature. For whole-embryo dpERK staining, fixed embryos
were dehydrated in a graded methanol series and then treated with
5% H2O2 for 1 hr. Rehydrated embryos were processed as
previously described [68]. Signal was detected using DAB
substrate kit for peroxidase (Vector). Alexa-488, Alexa-594, or
anti-rabbit-HRP (Dako) conjugated secondary antibodies were
used to detect primary antibodies. F-actin was detected using
phalloidin conjugated to Alexa-488 (Molecular Probes).
Cell counting and measurement of cochlear length
For cochlear and vestibular HC counting, E16.5–E18.5 samples
stained with Myo7a or expressing Atoh1-GFP were used since
most Fgfr1 mutants die before birth. Inner and outer HC were
distinguished by location and morphology as described previously
[21]. Group of single row of HCs was regarded as IHCs since they
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were located medial side of p75-expressing pillar cells. Relative
cochlear length was measured using ImageJ software. For
evaluation of HC number per length, we counted more than
300 mm regions of the base, middle, and apex of the cochlea and
normalized counts to 100 mm (more than n= 4 in each HC type)
as described [21]. For Sox2-positive cell counting, cross sections
from E14.5 samples were made and middle turn of cochlear duct
stained with anti-Sox2 antibody was chosen.
RNA in situ hybridization
RNA in situ hybridization on cryo-sections was performed as
previously described [69].
Paint-filling
The gross anatomy of bony labyrinths at E14.5 was visualized
by paint-filling as previously described [29]. Briefly, decapitated
heads were fixed in Bodian’s fixative over night. Specimens were
subsequently immersed in a graded ethanol series to dehydrate,
and cleared in a 2:1 mixture of benzyl benzoate and benzoic acid
(BABB). The inner ears were visualized by injection of 1% white
paint in BABB into the common crus.
Bromo-deoxyuridine incorporation assay
BrdU (100 mg/g body weight) was injected into pregnant mice
intra-peritoneally at E10.5–E14.5. BrdU injected mice were
sacrificed 2 hours after injection, and then fixed in 4% PFA.
BrdU-positive cells were counted in at least four cross sections of
the cochlear apical (at E12.5) or middle (at E14.5) turn. For E14.5
samples, only BrdU-labelled cells in Ko¨lliker’s organ were
counted. Data shown are mean 6 SD. P-values were calculated
using unpaired t-test, to determine the significance of the
difference between experimental and control samples.
Quantitative reverse transcription PCR
Whole otocyst or cochlear epithelial cells were dissected from
embryos at E10.5–E14.5 (at least n= 2 in each sample). Enzymatic
treatment was conducted to remove mesenchyme [70]. Total
RNA from pure otic epithelial cells was extracted using the
RNAqueous-Micro kit (#AM1931, Ambion, Austin, TX) and
then reverse-transcribed using First Strand cDNA Synthesis Kit
for RT-PCR (#11483188001, Roche, Indianapolis, IN). Synthe-
sized cDNA and primer sets were mixed with Power SYBR Green
PCR Master Mix (#4367669, Applied Biosystems, Warrington,
UK), and real-time quantitative PCR was performed using an ABI
Prism 7900 Sequence Detection System (Applied Biosystems). All
reactions were carried out in duplicate. The relative amount of
mRNA was calculated by standard curve method, and normalized
to that of 36B4 mRNA [71]. P-values were calculated using
unpaired t-test, to determine the significance of the difference
between experimental and control samples.
Immunoblotting
E12.5 or E14.5 cochlear epithelial cells, purified from under-
lying mesenchymal cells were lysed in a buffered solution,
consisting of SDS, salt, phosphatase inhibitor, and proteinase
inhibitor. A mixture of lysate, sample buffer, and 2-mercaptoeth-
anol, were boiled at 98uC for 2 min and separated on a SuperSep
Ace gel (Wako), and subsequently transferred into PVDF
membrane (GE Healthcare). The following antibodies were used:
rabbit anti-Akt antibody (1: 1000) (#9272, Cell Signalling
Technology), anti-Sox2 (1: 1000) (#AB5603, Millipore, Temecula,
CA), rabbit anti-Phospho Akt antibody (1: 1000) (#9271, Cell
Signalling Technology), and anti-Actin antibody (1: 10000) (MBL).
Horseradish peroxidase-linked anti-rabbit IgGs were used as
secondary antibodies (1:10,000) (GE Healthcare) and revealed
using Amersham ECL Prime Western Blotting Detection Reagent
(GE Healthcare) according to the manufacturer’s instruction.
ImageJ software was used to compare the relative Sox2 protein
amount between control and Fgfr1 mutants.
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